Keywords
selective serotonin reuptake inhibitors
, depression
, nonresponse
, optimization
, augmentation strategies
, lithium
, thyroid
, pindolol
, tricyclic antidepressants
, bupropion
, monoamine oxidase inhibitors
, venlafaxine
, mirtazapine
, psychotherapy